1. Press releases

   Team Europe: The European Union disburses €25 million to mitigate the effects of the coronavirus crisis in The Gambia

   Today, the European Union disbursed €25 million of budget support for The Gambia's response to the coronavirus pandemic. As part of the Team Europe global package, these funds contribute to the recovery from the pandemic and also support the transition towards democracy and medium-term

   Author: Strategic Communications - Publication date: 19/10/2020

2. Council Conclusions

   European Council conclusions on COVID-19 and climate change, 15 October 2020

   The European Council assessed the current epidemiological situation, which is unprecedented and gives rise to very serious concern.

   Author: EEAS Press Team - Publication date: 16/10/2020

3. Press releases

   Coronavirus: Commission lists key steps for effective vaccination strategies and vaccines deployment

   As Europe learns to live with the pandemic, the development and swift global deployment of safe and effective vaccines against COVID-19 remains an essential element in the eventual solution to the public health crisis.

   Author: Strategic Communications - Publication date: 15/10/2020

4. Press releases

   Coronavirus: Commission signs a joint procurement contract with Gilead for the supply of Remdesivir

   The Commission has signed a joint procurement framework contract with the pharmaceutical company Gilead for the supply of up to 500,000 treatment courses of Veklury, the brand name for Remdesivir, and the opportunity to increase supply beyond the 500,000 treatment courses.

   Author: Strategic Communications - Publication date: 08/10/2020

5. Press releases

   Coronavirus: the Commission approves third contract to ensure access to a potential vaccine

   Today, the European Commission approved a third contract with a pharmaceutical company, Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

   Author: Strategic Communications - Publication date: 08/10/2020

6. Press releases

   Ukraine: €10 million in humanitarian aid to withstand winter and coronavirus pandemic

   The European Commission has allocated additional €10 million in humanitarian aid to support the most vulnerable people in eastern Ukraine ahead of the upcoming winter and in response to the ongoing coronavirus pandemic. This brings EU humanitarian funding for eastern Ukraine in 2020 to €23 million.

   Author: Strategic Communications - Publication date: 06/10/2020

7. News stories
   

   #TeamEurope contre la COVID-19: La solidarité européenne se concrétise à travers un appui médical au Niger

   Les 9 et 11 septembre 2020, les régions de Zinder et Maradi ont bénéficié d’un appui en matériel médical dans la lutte contre la pandémie du COVID-19. Fourni par des partenaires européens présents au Niger, La Mission EUCAP Sahel Niger a transporté le matériel en région.

   Author: Strategic Communications - Publication date: 30/09/2020

8. Press releases

   EU and Georgia sign Financing Agreements for COVID-19 Recovery worth €129 million

   Today, Commissioner for Neighbourhood and Enlargement Olivér Várhelyi and the Prime Minister of Georgia, Giorgi Gakharia, signed two financing agreements worth €129 million to assist Georgia in coping with the COVID-19 outbreak and its impact on the country's economy.

   Author: Strategic Communications - Publication date: 29/09/2020

9. Press releases

   Questions and Answers: Coronavirus and the EU Vaccines Strategy

   On 17 June, the European Commission presented a European strategy to accelerate the development, manufacturing and deployment of vaccines against COVID-19. The EU Vaccines Strategy intends to ensure the production in Europe of qualitative, safe and efficacious vaccines, and to secure swift access to

   Author: Strategic Communications - Publication date: 24/09/2020

10. Press releases

    Coronavirus Global Response: the Commission's contribution to the COVID-19 Vaccine Global Access Facility (COVAX)

    Today, the European Commission confirmed its participation in the COVAX Facility for equitable access to affordable COVID-19 vaccines, following its expression of interest on 31 August and its announcement of a contribution of €400 million.

    Author: Strategic Communications - Publication date: 24/09/2020

Pages